Real Chemistry

Real Chemistry is a global healthcare communications network with 25 years of experience serving the pharmaceutical, biotech, and life sciences industries. The company operates across 28 countries with main hubs in major markets including New York, San Francisco, Boston, London, and Munich. Real Chemistry reports that all top 20 pharmaceutical companies work with them, positioning the firm as a tier-one commercialization partner for bringing medicines to market.

The company's capabilities span medical communications, commercial marketing, creative services, precision media, data analytics, and strategic advisory services. Real Chemistry emphasizes its integration of AI technologies across its service offerings, from predictive analytics to content generation. The firm operates through multiple practice areas including RC Resolve for regulatory and business advisory, 21GRAMS for creative services, and specialized groups for medical affairs, publications, and investor relations.

In 2025, Medical Marketing & Media named Real Chemistry Healthcare Network of the Year. The company has grown through strategic acquisitions, integrating more than 10 companies to build its current portfolio of capabilities and global reach.

Organizations should consider Real Chemistry when they need a comprehensive commercialization partner capable of coordinating complex, multi-disciplinary initiatives across global markets. The firm's strength lies in its ability to assemble integrated teams combining medical expertise, creative services, analytics, and strategic counsel within the regulatory constraints of pharmaceutical marketing.

Clients can expect enterprise-level infrastructure, established relationships with healthcare stakeholders, and AI-enabled capabilities developed over years of healthcare-specific application. The company reports that clients working with Real Chemistry experienced double the growth rate compared to those who did not, though specific methodology was not detailed.

Real Chemistry operates exclusively in healthcare with particular concentration in pharmaceutical and biotech sectors. The company's 25-year history is built specifically on translating complex science for medical audiences and commercializing therapies. Services address the complete pharmaceutical lifecycle from medical strategy and publications through commercial launch, market access, precision media targeting healthcare professionals, and investor relations for life sciences companies.

The firm maintains specialized expertise in regulatory environments, medical education requirements, and the unique challenges of healthcare marketing compliance. Their RC Resolve practice specifically addresses regulatory and value inflection points critical to pharmaceutical business strategy.

The ideal client is a mid-to-large pharmaceutical or biotech company preparing for a significant product launch or managing a complex brand portfolio across multiple markets. These organizations value integrated service delivery, require regulatory expertise, and need partners who can coordinate medical affairs, commercial strategy, creative execution, and analytics as a unified offering rather than through multiple vendors.